Login / Signup

C1QA and C1QC modify age-at-onset in familial amyloid polyneuropathy patients.

Andreia DiasDiana SantosTeresa CoelhoMiguel Alves-FerreiraJorge SequeirosIsabel AlonsoAlda SousaCarolina Lemos
Published in: Annals of clinical and translational neurology (2019)
C1QA was associated with later onset, whereas C1QC may have a double role: variants may confer earlier or later AO. As found in a study in Cyprus, we confirmed the role of complement C1Q genes (and thus of inflammation) as modulator of AO in Portuguese patients with TTR-FAP Val30Met.
Keyphrases
  • end stage renal disease
  • ejection fraction
  • newly diagnosed
  • chronic kidney disease
  • oxidative stress
  • prognostic factors
  • copy number
  • genome wide
  • patient reported outcomes